Lux Health Tech Acquisition Corp. is a blank check company sponsored by an affiliate of Lux Capital and formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses at the intersection of the healthcare and technology industries.
Company profile
Ticker
LUXA, LUXAU, LUXAW
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
852825321
LUXA stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
8 Nov 22
25-NSE
Exchange delisting
28 Oct 22
8-K
Lux Health Tech Acquisition Corp. Announces Cancellation of Special Meeting of Stockholders and Liquidation
7 Oct 22
DEF 14A
Definitive proxy
20 Sep 22
PRER14A
Preliminary revised proxy
20 Sep 22
PRE 14A
Preliminary proxy
7 Sep 22
8-K
Lux Health Tech Acquisition Corp. Signs Letter of Intent for a Business Combination
6 Sep 22
UPLOAD
Letter from SEC
1 Sep 22
CORRESP
Correspondence with SEC
31 Aug 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
Latest ownership filings
SC 13G/A
Lux Encore Sponsor, LP
19 Jan 23
SC 13G
Sculptor Capital LP
24 May 22
SC 13G/A
D1 Capital Partners L.P.
14 Feb 22
SC 13G
Weiss Asset Management LP
11 Feb 22
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
3 Feb 22
SC 13G/A
Wolfswood Holdings, LLC
4 Jun 21
SC 13G
D1 Capital Partners L.P.
16 Feb 21
SC 13G
MANULIFE FINANCIAL CORP
3 Feb 21
SC 13G
Lux Encore Sponsor, LP
29 Jan 21
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
25 Jan 21
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Institutional ownership, Q3 2022
13F holders | Current |
---|---|
Total holders | 75 |
Opened positions | 52 |
Closed positions | 11 |
Increased positions | 18 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 549.27 mm |
Total shares | 43.53 mm |
Total puts | 39.20 k |
Total calls | 0.00 |
Total put/call ratio | Infinity |
Largest owners | Shares | Value |
---|---|---|
Lux Encore Sponsor | 8.51 mm | $91.43 mm |
Empyrean Capital Partners | 3.00 mm | $30.05 mm |
MFC Manulife Financial | 2.93 mm | $31.53 mm |
Sculptor Capital | 2.02 mm | $20.23 mm |
Weiss Asset Management | 1.81 mm | $18.12 mm |
Wolfswood | 1.44 mm | $14.42 mm |
Marshall Wace | 1.38 mm | $13.80 mm |
Integrated Core Strategies | 1.27 mm | $12.46 mm |
Balyasny Asset Management | 1.24 mm | $12.44 mm |
Mizuho Markets Americas | 1.24 mm | $12.43 mm |